Remove Biopharma Remove Collaboration Remove Ecosystems Remove Government
article thumbnail

Achieve competitive advantage in precision medicine with IBM and Amazon Omics

IBM Business Partners

However, healthcare and biopharma community tend to agree that pursuing population-level multimodal and multi-omic research is cost-prohibitive using the traditional data center infrastructure. All of these features help with an accelerated time to market, along with developing a secure, scalable omics processing pipeline.